These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 3995682
1. Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Hait WN, Grais L, Benz C, Cadman EC. Cancer Chemother Pharmacol; 1985; 14(3):202-5. PubMed ID: 3995682 [Abstract] [Full Text] [Related]
2. Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Hait WN, Lee GL. Biochem Pharmacol; 1985 Nov 15; 34(22):3973-8. PubMed ID: 4062971 [Abstract] [Full Text] [Related]
3. Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin. Lee GL, Hait WN. Life Sci; 1985 Jan 28; 36(4):347-54. PubMed ID: 2981390 [Abstract] [Full Text] [Related]
4. Calmodulin and protein kinase C antagonists also inhibit the Ca2+-dependent protein protease, calpain I. Brumley LM, Wallace RW. Biochem Biophys Res Commun; 1989 Mar 31; 159(3):1297-303. PubMed ID: 2539150 [Abstract] [Full Text] [Related]
5. Melittin binding causes a large calcium-dependent conformational change in calmodulin. Kataoka M, Head JF, Seaton BA, Engelman DM. Proc Natl Acad Sci U S A; 1989 Sep 31; 86(18):6944-8. PubMed ID: 2780551 [Abstract] [Full Text] [Related]
8. Calcium release from calmodulin and its C-terminal or N-terminal halves in the presence of the calmodulin antagonists phenoxybenzamine and melittin measured by stopped-flow fluorescence with Quin 2 and intrinsic tyrosine. Inhibition of calmodulin-dependent protein kinase of cardiac sarcoplasmic reticulum. Suko J, Wyskovsky W, Pidlich J, Hauptner R, Plank B, Hellmann G. Eur J Biochem; 1986 Sep 15; 159(3):425-34. PubMed ID: 3758070 [Abstract] [Full Text] [Related]
9. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells. Ganapathi R, Grabowski D, Turinic R, Valenzuela R. Eur J Cancer Clin Oncol; 1984 Jun 15; 20(6):799-806. PubMed ID: 6540180 [Abstract] [Full Text] [Related]
10. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists. Lazo JS, Hait WN, Kennedy KA, Braun ID, Meandzija B. Mol Pharmacol; 1985 Mar 15; 27(3):387-93. PubMed ID: 2579318 [Abstract] [Full Text] [Related]
11. Protection by chlorpromazine, albumin and bivalent cations against haemolysis induced by melittin, [Ala-14]melittin and whole bee venom. Rudenko SV, Nipot EE. Biochem J; 1996 Aug 01; 317 ( Pt 3)(Pt 3):747-54. PubMed ID: 8760358 [Abstract] [Full Text] [Related]
12. Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes. Gerst JE, Salomon Y. Endocrinology; 1987 Nov 01; 121(5):1766-72. PubMed ID: 3665846 [Abstract] [Full Text] [Related]
15. Ca2+-dependent high-affinity complex formation between calmodulin and melittin. Comte M, Maulet Y, Cox JA. Biochem J; 1983 Jan 01; 209(1):269-72. PubMed ID: 6847615 [Abstract] [Full Text] [Related]
16. Phenothiazine inhibition of calmodulin stimulates calcium-dependent potassium efflux in human red blood cells. Plishker GA. Cell Calcium; 1984 Apr 01; 5(2):177-85. PubMed ID: 6234067 [Abstract] [Full Text] [Related]
17. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin. Hait WN, Gesmonde JF, Lazo JS. Anticancer Res; 1994 Apr 01; 14(5A):1711-21. PubMed ID: 7531409 [Abstract] [Full Text] [Related]